Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Role of imatinib mesylate (Gleevec®/Glivec®) in gastrointestinal stromal tumors. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1097/00000658-200001000-00008
10.1097/00000658-200001000-00008 · External reference
10.1007/s004280000338
10.1007/s004280000338 · External reference
10.1016/s0046-8177(99)90040-0
10.1016/s0046-8177(99)90040-0 · External reference
10.1007/s11864-001-0070-0
10.1007/s11864-001-0070-0 · External reference
10.1097/00000478-198309000-00001
10.1097/00000478-198309000-00001 · External reference
10.1126/science.279.5350.577
10.1126/science.279.5350.577 · External reference
Unresolved reference
External reference
10.1053/hupa.2002.123545
10.1053/hupa.2002.123545 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene
1992 · External reference
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
2000 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1097/00000478-199904000-00002
10.1097/00000478-199904000-00002 · External reference
Unresolved reference
External reference
10.1016/s0959-8049(02)80601-3
10.1016/s0959-8049(02)80601-3 · External reference
10.1097/00000478-199901000-00009
10.1097/00000478-199901000-00009 · External reference
10.1016/s1470-2045(02)00899-9
10.1016/s1470-2045(02)00899-9 · External reference
10.1200/jco.2000.18.18.3211
10.1200/jco.2000.18.18.3211 · External reference
10.1002/(sici)1097-0142(20000101)88:1<66::aid-cncr10>3.0.co;2-0
10.1002/(sici)1097-0142(20000101)88:1<66::aid-cncr10>3.0.co;2-0 · External reference
10.1200/jco.1999.17.1.150
10.1200/jco.1999.17.1.150 · External reference
Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors
2002 · External reference
10.1016/s0959-8049(02)80608-6
10.1016/s0959-8049(02)80608-6 · External reference
10.1016/s0959-8049(02)80599-8
10.1016/s0959-8049(02)80599-8 · External reference
10.1016/s0304-419x(97)00022-x
10.1016/s0304-419x(97)00022-x · External reference
Lessons learned from the development of an ABL tyrosine kinase inhibitor for chronic myelogenous leukemia. j Clin
10.1172/jci9083 · 2000 · External reference
KIT signal transduction. Hematol Oncol Clin
2000 · External reference
10.1016/s0022-3565(24)38879-2
10.1016/s0022-3565(24)38879-2 · External reference
Unresolved reference
External reference
10.1038/nm0596-561
10.1038/nm0596-561 · External reference
10.1016/s0959-8049(01)00237-4
10.1016/s0959-8049(01)00237-4 · External reference
10.1056/nejm199907153410306
10.1056/nejm199907153410306 · External reference
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl
2001 · External reference
10.1038/sj.onc.1204704
10.1038/sj.onc.1204704 · External reference
Unresolved reference
External reference
10.1182/blood.v96.3.925.015k50_925_932
10.1182/blood.v96.3.925.015k50_925_932 · External reference
Unresolved reference
External reference
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl
2001 · External reference
10.1056/nejm200104053441404
10.1056/nejm200104053441404 · External reference
10.1016/s0140-6736(01)06535-7
10.1016/s0140-6736(01)06535-7 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl
2002 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1093/jnci/94.16.1247
10.1093/jnci/94.16.1247 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1016/s0959-8049(02)00836-5
10.1016/s0959-8049(02)00836-5 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1093/jnci/92.3.205
10.1093/jnci/92.3.205 · External reference
10.1038/sj.bjc.6600965
10.1038/sj.bjc.6600965 · External reference
Unresolved reference
External reference
KiTgene mutations in gastrointestinal stromal tumors: more complex than previously recognized? Am
2002 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1053/hupa.2002.124124
10.1053/hupa.2002.124124 · External reference
10.1126/science.1079666
10.1126/science.1079666 · External reference
10.1124/pr.55.3.4
10.1124/pr.55.3.4 · External reference
Unresolved reference
External reference
10.1016/s0002-9440(10)64343-x
10.1016/s0002-9440(10)64343-x · External reference
Pharmacotherapy of gastrointestinal stromal tumours. Expert Opin
2003 · External reference
Unresolved reference
External reference
apos;Brien SG, Ford JM et al Practical management of patients with chronic myeloid leukemia receiving imatinib. j Gun
2003 · External reference
10.1634/theoncologist.7-5-390
10.1634/theoncologist.7-5-390 · External reference
10.1097/00001813-200209000-00010
10.1097/00001813-200209000-00010 · External reference
